Tumour-released exosomes and their implications in cancer immunity. (Q36969017)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Tumour-released exosomes and their implications in cancer immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Stefano Fais

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Licia Rivoltini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Iero M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Valenti R

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Filipazzi P

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Parmiani G

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

12 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

Cell Death & Differentiation

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

80-88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17932500%20AND%20SRC:MED&resulttype=core&format=json

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

A cytokine-mediated link between innate immunity, inflammation, and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Cancer antigens: immune recognition of self and altered self

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Rules for making human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Immune resistance orchestrated by the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Immunosuppressive strategies that are mediated by tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Mechanisms and functional significance of tumour-induced dendritic-cell defects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Impaired circulating myeloid DCs from myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Dendritic cell subsets in childhood and in children with cancer: relation to age and disease prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

VEGF as a mediator of tumor-associated immunodeficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Exosomes: a common pathway for a specialized function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Exosomes: composition, biogenesis and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Malignant effusions and immunogenic tumour-derived exosomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Human Colorectal Cancer Cells Induce T-Cell Death Through Release of Proapoptotic Microvesicles: Role in Immune Escape

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Proteomic analysis of exosomes secreted by human mesothelioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Tumor-released microvesicles as vehicles of immunosuppression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

RETRACTED: Pregnancy-associated exosomes and their modulation of T cell signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Tumor exosomes inhibit differentiation of bone marrow dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Exosomes: endosomal-derived vesicles shipping extracellular messages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Lysosomes and autophagy in cell death control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

The regulation of exosome secretion: a novel function of the p53 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

The V0-ATPase mediates apical secretion of exosomes containing Hedgehog-related proteins in Caenorhabditis elegans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Exosome secretion: the art of reutilizing nonrecycled proteins?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Vaccination of stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Calreticulin exposure dictates the immunogenicity of cancer cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

Principles and use of anti-CTLA4 antibody in human cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021

DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402237

7 January 2021